Repositioning of an existing drug for the neglected tropical disease Onchocerciasis

Onchocerciasis, or river blindness, is a neglected tropical disease caused by the filarial nematode Onchocerca volvulus that affects more than 37 million people, mainly in third world countries. Currently, the only approved drug available for mass treatment is ivermectin, however, drug resistance is beginning to emerge, thus, new therapeutic targets and agents are desperately needed to treat and cure this devastating disease. Chitin metabolism plays a central role in invertebrate biology due to the critical structural function of chitin for the organism. Taken together with its absence in mammals, targeting chitin is an appealing therapeutic avenue. Importantly, the chitinase OvCHT1 from O. volvulus was recently discovered, however, its exact role in the worm’s metabolism remains unknown. A screening effort against OvCHT1 was conducted using the Johns Hopkins Clinical Compound Library that contains over 1,500 existing drugs. Closantel, a veterinary anthelmintic with known proton ionophore activities, was identified as a potent and specific inhibitor of filarial chitinases, an activity not previously reported for this compound. Notably, closantel was found also to completely inhibit molting of O. volvulus infective L3 stage larvae. Closantel appears to target two important biochemical processes essential to filarial parasites. To begin to unravel closantel’s effects, a retro-fragment-based study was used to define structural elements critical for closantel’s chitinase inhibitor function. As resources towards the development of new agents that target neglected tropical diseases are scant, the finding of an existing drug with impact against O. volvulus provides promise in the hunt for new therapies against river blindness.

[1]  R. Isaac,et al.  Unravelling the moulting degradome: new opportunities for chemotherapy? , 2007, Trends in parasitology.

[2]  J. McKerrow,et al.  Cloning of a Cysteine Protease Required for the Molting of Onchocerca volvulus Third Stage Larvae* , 1996, The Journal of Biological Chemistry.

[3]  L. Konaté,et al.  Feasibility of Onchocerciasis Elimination with Ivermectin Treatment in Endemic Foci in Africa: First Evidence from Studies in Mali and Senegal , 2009, PLoS neglected tropical diseases.

[4]  S. Williams,et al.  Chitinase genes expressed by infective larvae of the filarial nematodes, Acanthocheilonema viteae and Onchocerca volvulus. , 1996, Molecular and biochemical parasitology.

[5]  Steven A. Williams,et al.  Characterization of a Novel Filarial Serine Protease Inhibitor, Ov-SPI-1, from Onchocerca volvulus, with Potential Multifunctional Roles during Development of the Parasite* , 2005, Journal of Biological Chemistry.

[6]  A. Prince,et al.  Onchocerca volvulus: biochemical and morphological characteristics of the surface of third- and fourth-stage larvae. , 1990, Experimental parasitology.

[7]  S. Ōmura,et al.  The life and times of ivermectin — a success story , 2004, Nature Reviews Microbiology.

[8]  D. Boakye,et al.  Thirty-month follow-up of sub-optimal responders to multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.

[9]  D. V. van Aalten,et al.  Natural product family 18 chitinase inhibitors. , 2005, Natural product reports.

[10]  C. Chong,et al.  New uses for old drugs , 2007, Nature.

[11]  H. van den Bossche,et al.  Closantel, a new antiparasitic hydrogen ionophore [proceedings]. , 1979, Archives internationales de physiologie et de biochimie.

[12]  M. Boussinesq,et al.  Effect of single-dose ivermectin on Onchocerca volvulus: a systematic review and meta-analysis. , 2008, The Lancet. Infectious diseases.

[13]  C. Mackenzie,et al.  Immunocompetence may be important in the effectiveness of Mectizan (ivermectin) in the treatment of human onchocerciasis. , 2002, Acta tropica.

[14]  Jing Liu,et al.  RNA interference targeting cathepsin L and Z-like cysteine proteases of Onchocerca volvulus confirmed their essential function during L3 molting. , 2004, Molecular and biochemical parasitology.

[15]  Paul A Wender,et al.  Function-oriented synthesis, step economy, and drug design. , 2008, Accounts of chemical research.

[16]  S. Sakuda,et al.  Expression and Secretion of a Larval-specific Chitinase (Family 18 Glycosyl Hydrolase) by the Infective Stages of the Parasitic Nematode, Onchocerca volvulus * , 2001, The Journal of Biological Chemistry.

[17]  S. Gåseidnes,et al.  Structural insights into the catalytic mechanism of a family 18 exo-chitinase , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[18]  G. Gooday,et al.  Chitin in egg shells of Onchocerca gibsoni and Onchocerca volvulus. , 1987, Molecular and biochemical parasitology.

[19]  D. Boakye,et al.  Prevalence and intensity of Onchocerca volvulus infection and efficacy of ivermectin in endemic communities in Ghana: a two-phase epidemiological study , 2007, The Lancet.

[20]  P. Loiseau,et al.  Lymphotropic antifilarial agents derived from closantel and chlorambucil. , 1997, International journal for parasitology.

[21]  I. Fairweather,et al.  The effect of the hydrogen ionophore closantel upon the pharmacology and ultrastructure of the adult liver flukeFasciola hepatica , 2004, Parasitology Research.

[22]  R. Fimmers,et al.  Wolbachia endobacteria depletion by doxycycline as antifilarial therapy has macrofilaricidal activity in onchocerciasis: a randomized placebo-controlled study , 2007, Medical Microbiology and Immunology.

[23]  R. Lucius,et al.  Essential Role of Chitinase in the Development of the Filarial Nematode Acanthocheilonema viteae , 2007, Infection and Immunity.

[24]  T. Ashburn,et al.  Drug repositioning: identifying and developing new uses for existing drugs , 2004, Nature Reviews Drug Discovery.

[25]  J. Foster,et al.  The chitin synthase genes chs-1 and chs-2 are essential for C. elegans development and responsible for chitin deposition in the eggshell and pharynx, respectively. , 2005, Developmental biology.

[26]  María-Gloria Basáñez,et al.  River Blindness: A Success Story under Threat? , 2006, PLoS medicine.

[27]  Phillips,et al.  Cloning and expression of a Streptomyces plicatus chitinase (chitinase-63) in Escherichia coli. , 1988, The Journal of biological chemistry.

[28]  S. Ōmura Ivermectin: 25 years and still going strong. , 2008, International journal of antimicrobial agents.

[29]  R. Pink,et al.  Opportunities and Challenges in Antiparasitic Drug Discovery , 2005, Nature Reviews Drug Discovery.

[30]  J. Foster,et al.  Parasitic nematodes have two distinct chitin synthases. , 2005, Molecular and biochemical parasitology.

[31]  D. Boakye,et al.  An investigation of persistent microfilaridermias despite multiple treatments with ivermectin, in two onchocerciasis-endemic foci in Ghana , 2004, Annals of tropical medicine and parasitology.

[32]  R. Martin,et al.  Modes of action of anthelmintic drugs. , 1997, Veterinary journal.

[33]  Peter J. Hotez,et al.  Neglected Tropical Diseases in Sub-Saharan Africa: Review of Their Prevalence, Distribution, and Disease Burden , 2009, PLoS neglected tropical diseases.

[34]  S. Ōmura,et al.  Specificity and affinity of natural product cyclopentapeptide inhibitors against A. fumigatus, human, and bacterial chitinases. , 2004, Chemistry & biology.

[35]  M. Cotreau,et al.  The Antiparasitic Moxidectin: Safety, Tolerability, and Pharmacokinetics in Humans , 2003, Journal of clinical pharmacology.

[36]  Akira Isogai,et al.  The structure of allosamidin, a novel insect chitinase inhibitor, produced by Streptomyces Sp. , 1986 .

[37]  K. Mehta,et al.  Transglutaminase-catalyzed reaction is important for molting of Onchocerca volvulus third-stage larvae , 1995, Antimicrobial agents and chemotherapy.

[38]  A. Hoerauf,et al.  Of Mice, Cattle, and Humans: The Immunology and Treatment of River Blindness , 2008, PLoS neglected tropical diseases.

[39]  D. Kaslow,et al.  Transmission-blocking activity of a chitinase inhibitor and activation of malarial parasite chitinase by mosquito protease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Taylor,et al.  Pharmacokinetics of a novel closantel/ivermectin injection in cattle. , 2006, Journal of veterinary pharmacology and therapeutics.

[41]  K. Spindler,et al.  Chitin metabolism: a target for drugs against parasites , 2004, Parasitology Research.

[42]  Adam R Renslo,et al.  Drug discovery and development for neglected parasitic diseases , 2006, Nature chemical biology.

[43]  Solomon Nwaka,et al.  Innovative lead discovery strategies for tropical diseases , 2006, Nature Reviews Drug Discovery.

[44]  A. E. Bianco,et al.  Chitinase is stored and secreted from the inner body of microfilariae and has a role in exsheathment in the parasitic nematode Brugia malayi , 2008, Molecular and biochemical parasitology.